Drug Type Oligonucleotide |
Synonyms Immune diseases therapy (Sanegene bio) |
Target- |
Mechanism RNA interference |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Immune System Diseases | IND Application | CN | 04 Sep 2024 |